Dr. Ransom is a graduate of the University of Iowa College of Medicine (1962) and was certified by the American Board of Allergy and Immunology in 1974. He is a Fellow of the American College of ...

On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on ...

While most sinus issues can be managed with nasal sprays, decongestants and antibiotics, some cases require surgical ...

Advent noses, clinically known as balloon sinuplasty devices, provide relief for chronic sinusitis sufferers when medications ...

London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a ...

Symptoms of sinusitis include a ... it may be chronic and can be diagnosed by an X-ray or CT scan at hospital. Appropriate treatment will then be given. Acute sinusitis will often settle on ...

GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Saturday, January 4, 2025, 09:00 Hrs [IST] GSK plc announced ...

(Alliance News) - GSK PLC on Friday reported that its Nucala treatment has been approved in China to treat long-term sufferers of a sinus ailment following a phase 3 study.